Antibody effector mechanisms in myasthenia gravis. The complement hypothesis.
Richman
D P
DP
Department of Neurology, University of California, Davis 95616, USA.
Agius
M A
MA
Kirvan
C A
CA
Gomez
C M
CM
Fairclough
R H
RH
Dupont
B L
BL
Maselli
R A
RA
D000818:Animals; D000906:Antibodies / Q000276:immunology; D000911:Antibodies, Monoclonal; D003165:Complement System Proteins / Q000276:immunology*; D006801:Humans; D018448:Models, Immunological; D009157:Myasthenia Gravis / Q000276:immunology* / Q000503:physiopathology; D009469:Neuromuscular Junction / Q000503:physiopathology
D000906:Antibodies; D000911:Antibodies, Monoclonal; D003165:Complement System Proteins